Researchers Identify Novel Drug Target for Treatment of Nephrotic Syndrome

Albuminuria is the hallmark of nephrotic syndrome (NS), a leading cause of chronic kidney disease that affects 500 million people worldwide, but the molecular mechanism underlying albuminuria-induced kidney injury remains poorly defined.  A recent study by researchers from Washington University School of Medicine have provided insight into a possible novel drug target to treat proteinuric […]